You can now read 10 articles a month for free. Read as much as you want anywhere and anytime for just 99¢.

FDA orders lower sleeping pill doses

WASHINGTON — The Food and Drug Administration on Thursday ordered makers of Ambien and similar sleeping pills to lower the dosage of their drugs, based on studies suggesting patients face a higher risk of injury due to morning drowsiness.

The agency said research shows that the drugs remain in the bloodstream at levels high enough to interfere with alertness and coordination, which increases the risk of car accidents.

Continue reading below

Regulators are requiring drug manufacturers to cut the dose in half for women, who process the drug more slowly. Doses will be loweredto 5 milligrams for regular products and to 6.25 milligrams for extended-release formulations.

The FDA is recommending that manufacturers apply these lower doses to men as well, though it is not making them a requirement.

The new doses apply to all insomnia treatments containing the drug zolpidem, which is sold under brands including Ambien, Edluar, Zolpimist, and in generic forms.

The FDA has received more than 700 reports of driving-related problems connected to zolpidem over the years.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week